These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20065206)

  • 21. Going off-label without venturing off-course: evidence and ethical off-label prescribing.
    Largent EA; Miller FG; Pearson SD
    Arch Intern Med; 2009 Oct; 169(19):1745-7. PubMed ID: 19858430
    [No Abstract]   [Full Text] [Related]  

  • 22. Antipsychotics in nursing homes.
    Salzman C
    J Clin Psychopharmacol; 2013 Feb; 33(1):1-2. PubMed ID: 23277258
    [No Abstract]   [Full Text] [Related]  

  • 23. How the FDA manages drug safety with black box warnings, use restrictions, and drug removal, with attention to gastrointestinal medications.
    Ehrenpreis ED; Ciociola AA; Kulkarni PM;
    Am J Gastroenterol; 2012 Apr; 107(4):501-4. PubMed ID: 22475958
    [No Abstract]   [Full Text] [Related]  

  • 24. A physician's prerogative to prescribe drugs for off-label uses during pregnancy.
    Rayburn WF
    Obstet Gynecol; 1993 Jun; 81(6):1052-5. PubMed ID: 8497349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'Off-label' prescribing, the Physician's Desk Reference and the court.
    Spector RA; Marquez E
    J La State Med Soc; 2011; 163(5):276-80. PubMed ID: 22272550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why and how antipsychotic drugs are used in 40 Sydney nursing homes.
    Snowdon J; Day S; Baker W
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1146-52. PubMed ID: 16315158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of antipsychotic agents in the management of behavioral disorders in the elderly with dementia: evaluating recent clinical data.
    Worz CR
    Director; 2008; 16(2):17-20. PubMed ID: 19343879
    [No Abstract]   [Full Text] [Related]  

  • 28. The "art" of medicine and the "smokescreen" of the randomized trial off-label use of vascular devices.
    Ansel GM; Jaff MR
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):998-1002. PubMed ID: 19021289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Off-label use: an industry perspective on expanding use beyond approved indications.
    Russell ME; Friedman MI; Mascioli SR; Stolz LE
    J Interv Cardiol; 2006 Oct; 19(5):432-8. PubMed ID: 17020568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staying on track when prescribing off-label.
    Fitzgerald AS; O'Malley PG
    Am Fam Physician; 2014 Jan; 89(1):4-5. PubMed ID: 24444499
    [No Abstract]   [Full Text] [Related]  

  • 31. Adherence to black box warnings for prescription medications in outpatients.
    Lasser KE; Seger DL; Yu DT; Karson AS; Fiskio JM; Seger AC; Shah NR; Gandhi TK; Rothschild JM; Bates DW
    Arch Intern Med; 2006 Feb; 166(3):338-44. PubMed ID: 16476875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Off-label prescribing explained. Why your doctor may recommend meds that aren't FDA-approved for your condition.
    Johns Hopkins Med Lett Health After 50; 2011 Jun; 23(4):7. PubMed ID: 21702115
    [No Abstract]   [Full Text] [Related]  

  • 33. Real-world antipsychotic treatment practices.
    Moore TA; Covell NH; Essock SM; Miller AL
    Psychiatr Clin North Am; 2007 Sep; 30(3):401-16. PubMed ID: 17720029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with choice of antipsychotic treatment in elderly veterans: potential confounders for observational studies.
    Pratt N; Roughead E; Salter A; Ryan P
    Aust N Z J Public Health; 2010 Dec; 34(6):589-93. PubMed ID: 21134060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Off-label medication use in an academic hospital pediatric critical care unit.
    Hsu B; Brazelton T
    WMJ; 2009 Oct; 108(7):343-8. PubMed ID: 19886581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Off-label pharmaceutical use: balancing information, risks, and benefits.
    Kozma CM
    Manag Care Interface; 2004 Jan; 17(1):29-30. PubMed ID: 15035597
    [No Abstract]   [Full Text] [Related]  

  • 37. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics.
    Novak E; Allen PJ
    Pediatr Nurs; 2007; 33(1):64-70. PubMed ID: 17411005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of wording in "Dear doctor" letters and in black box labels.
    Weatherby LB; Nordstrom BL; Fife D; Walker AM
    Clin Pharmacol Ther; 2002 Dec; 72(6):735-42. PubMed ID: 12496755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescribing psychoactive medications in nursing homes: current practice in Singapore.
    Mamun K; Goh-Tan CY; Ng LL
    Singapore Med J; 2003 Dec; 44(12):625-9. PubMed ID: 14770256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.